(FOLD) Amicus Therapeutics - Performance -36.9% in 12m
Compare FOLD with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-49.22%
#66 in Group
Rel. Strength
17.02%
#6603 in Universe
Total Return 12m
-36.92%
#83 in Group
Total Return 5y
-50.46%
#58 in Group
P/E -
(?) Percentile in Group
P/E Forward 370
92th Percentile in Group
PEG -0.18
42th Percentile in Group
FCF Yield 0.07%
77th Percentile in Group
12m Total Return: FOLD (-36.9%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: FOLD vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for FOLD
| Total Return (including Dividends) | FOLD | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -13.21% | 2.02% | 2.87% |
| 3 Months | -37.97% | -15.44% | -6.42% |
| 12 Months | -36.92% | -14.02% | 9.87% |
| 5 Years | -50.46% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | FOLD | XBI | S&P 500 |
| 1 Month | -31.4% | 57% | 89.4% |
| 3 Months | -93.4% | -82.3% | -72% |
| 12 Months | -65.2% | -53.1% | 49.3% |
| 5 Years | -32.3% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #184 | -14.9% | -15.6% |
| 3 Month | #144 | -26.6% | -33.7% |
| 12 Month | #83 | -26.6% | -42.6% |
| 5 Years | #59 | -32.6% | -76.1% |
FAQs
Does FOLD Amicus Therapeutics outperforms the market?
No,
over the last 12 months FOLD made -36.92%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months FOLD made -37.97%, while XBI made -15.44%.
Over the last 3 months FOLD made -37.97%, while XBI made -15.44%.
Performance Comparison FOLD vs Indeces and Sectors
FOLD vs. Indices FOLD is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -9.91% | -16.1% | -38.9% | -46.8% |
| US NASDAQ 100 | QQQ | -10.2% | -17.9% | -39.3% | -48.2% |
| US Dow Jones Industrial 30 | DIA | -10.2% | -14.8% | -37.9% | -43.3% |
| German DAX 40 | DAX | -12.0% | -32.5% | -64.5% | -62.0% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -10.6% | -19.5% | -38.1% | -42.6% |
| Hongkong Hang Seng | HSI | -13.4% | -29.4% | -48.4% | -49.0% |
| India NIFTY 50 | INDA | -7.52% | -15.5% | -40.8% | -39.3% |
| Brasil Bovespa | EWZ | -12.0% | -24.7% | -48.1% | -30.4% |
FOLD vs. Sectors FOLD is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -10.1% | -16.9% | -45.1% | -57.3% |
| Consumer Discretionary | XLY | -10.8% | -16.7% | -36.7% | -51.0% |
| Consumer Staples | XLP | -9.54% | -15.2% | -45.8% | -44.5% |
| Energy | XLE | -10.9% | -13.3% | -32.9% | -27.2% |
| Financial | XLF | -10.5% | -18.8% | -44.8% | -58.4% |
| Health Care | XLV | -6.12% | -8.83% | -33.7% | -31.0% |
| Industrial | XLI | -11.5% | -20.6% | -39.9% | -46.9% |
| Materials | XLB | -9.90% | -17.9% | -34.9% | -30.9% |
| Real Estate | XLRE | -9.58% | -19.3% | -41.3% | -50.4% |
| Technology | XLK | -10.8% | -20.0% | -36.6% | -43.9% |
| Utilities | XLU | -11.0% | -18.8% | -46.7% | -52.8% |
| Aerospace & Defense | XAR | -10.4% | -22.6% | -48.2% | -62.1% |
| Biotech | XBI | -1.83% | -15.2% | -17.9% | -22.9% |
| Homebuilder | XHB | -9.47% | -16.3% | -25.3% | -27.2% |
| Retail | XRT | -10.1% | -16.8% | -32.6% | -32.6% |